Mylan N.V. (NASDAQ:MYL) Earns “Sector Perform” Rating from Royal Bank Of Canada
Mylan N.V. (NASDAQ:MYL)‘s stock had its “sector perform” rating reiterated by equities researchers at Royal Bank Of Canada in a note issued to investors on Thursday. They presently have a $32.00 price target on the stock, down from their prior price target of $33.00. Royal Bank Of Canada’s target price would indicate a potential downside of 0.25% from the company’s previous close.
A number of other equities research analysts have also weighed in on MYL. Wells Fargo & Company restated a “market perform” rating and issued a $40.00 price objective on shares of Mylan N.V. in a report on Friday, April 14th. Deutsche Bank AG lowered their price objective on shares of Mylan N.V. from $52.00 to $51.00 and set a “buy” rating for the company in a report on Tuesday, April 18th. BMO Capital Markets initiated coverage on shares of Mylan N.V. in a report on Monday, May 1st. They issued an “outperform” rating and a $50.00 price objective for the company. Zacks Investment Research lowered shares of Mylan N.V. from a “hold” rating to a “sell” rating in a report on Monday, May 15th. Finally, Cowen and Company restated a “market perform” rating and issued a $43.00 price objective (down from $55.00) on shares of Mylan N.V. in a report on Sunday, May 21st. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $48.73.
Mylan N.V. (NASDAQ:MYL) traded up 0.8600% during trading on Thursday, reaching $32.3559. 8,124,749 shares of the company were exchanged. Mylan N.V. has a one year low of $29.58 and a one year high of $49.42. The firm’s 50-day moving average is $37.74 and its 200 day moving average is $39.09. The company has a market capitalization of $17.34 billion, a P/E ratio of 32.3236 and a beta of 1.27. Mylan N.V. also was the recipient of unusually large options trading activity on Monday. Investors acquired 9,410 call options on the company. This represents an increase of 250% compared to the typical volume of 2,688 call options.
Mylan N.V. (NASDAQ:MYL) last announced its quarterly earnings data on Wednesday, August 9th. The company reported $1.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.18 by $0.08. The business had revenue of $2.96 billion during the quarter, compared to the consensus estimate of $3 billion. Mylan N.V. had a return on equity of 23.69% and a net margin of 4.59%. The company’s revenue was up 15.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.16 earnings per share. On average, analysts anticipate that Mylan N.V. will post $4.86 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Mylan N.V. (NASDAQ:MYL) Earns “Sector Perform” Rating from Royal Bank Of Canada” was originally reported by Watch List News and is the property of of Watch List News. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://www.watchlistnews.com/mylan-n-v-nasdaqmyl-earns-sector-perform-rating-from-royal-bank-of-canada/1468862.html.
In other Mylan N.V. news, President Rajiv Malik sold 25,000 shares of the business’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $1,000,000.00. Following the transaction, the president now directly owns 799,855 shares of the company’s stock, valued at approximately $31,994,200. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Anthony Mauro sold 10,000 shares of the business’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $40.00, for a total transaction of $400,000.00. Following the transaction, the insider now directly owns 140,653 shares in the company, valued at $5,626,120. The disclosure for this sale can be found here. 0.69% of the stock is currently owned by insiders.
Several hedge funds have recently made changes to their positions in the stock. First Personal Financial Services boosted its stake in shares of Mylan N.V. by 33.2% in the first quarter. First Personal Financial Services now owns 2,733 shares of the company’s stock worth $107,000 after buying an additional 681 shares during the period. Global X Management Co. LLC boosted its stake in shares of Mylan N.V. by 91.6% in the first quarter. Global X Management Co. LLC now owns 3,015 shares of the company’s stock worth $118,000 after buying an additional 1,441 shares during the period. Ropes Wealth Advisors LLC acquired a new stake in shares of Mylan N.V. during the first quarter worth approximately $136,000. Oakworth Capital Inc. boosted its stake in shares of Mylan N.V. by 30.7% in the first quarter. Oakworth Capital Inc. now owns 4,255 shares of the company’s stock worth $166,000 after buying an additional 1,000 shares during the period. Finally, State of Alaska Department of Revenue acquired a new stake in shares of Mylan N.V. during the first quarter worth approximately $188,000. Hedge funds and other institutional investors own 70.19% of the company’s stock.
Mylan N.V. Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Receive News & Ratings for Mylan N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan N.V. and related companies with Analyst Ratings Network's FREE daily email newsletter.